Skip to main content
. 2018 Mar 6;10:60. doi: 10.3389/fnagi.2018.00060

Table 2.

Scores on all outcome measures for patient CS, age 74, over 12 month DFMO treatment period.

Measure Exam 1 (baseline) Exam 2 (3 months) Exam 3 (9 Months) Exam 4 (12 months)
MMSE (/30) 26 26 24 22
ADAS-Cog (/70) 30 34 31 33
Logical Memory, Immediate Recall (/25) 9 4 6 6
Logical Memory, Delayed Recall (/25) 3 3 3 6
Phonemic Fluency (FAS) 38 41 22 32
Phonemic Fluency (animals) 9 9 5 9
GDS (/15) 4 1 2 2
Subjective Cognitive Decline (/9) 6 6.5 4 5
Chase Test mps 0.167 0.133 0.233 0.366
Chase Test total errors 14 11 5 8
Chase Test feedback errors 14 11 5 8
GMLT mpsa 0.162 0.195 0.131 0.187
GMLT total errorsa 31.67 37.75 30.00 37.00
GMLT feedback errorsa 13.33 18.50 14.67 19.50
GMLT delayed recall: mps b b b 0.125
GMLT delayed recall: total errors b b b 30
GMLT delayed recall: feedback errors b b b 20
GMLT reverse recall: mps b b 0.141 0.163
GMLT reverse recall: total errors b b 30 67
GMLT reverse recall: feedback errors b b 12 44
One Card Learning: accuracy 0.964 0.891 0.904 0.785
One Card Learning: total errors 26 32 31 41
One Back Task: accuracy 0.860 0.747 0.927
One Back Task: total Errors 6 20 21 18
ISLT Total Learning (3 trials, /36) c 15 9 18
ISLT Delayed Recall (/12) c 2 1 2
Florbetapir PET SUVr 1.55 1.69
a

Averaged across 5 learning trials.

b

Patient did not complete for cognitive reasons.

c

Patient did not complete for technological reasons.